John Vincent
Pfizer (United States) · 92 works · 6,721 citations · h-index 31
Top works
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
- Eplerenone Reduces Mortality 30 Days After Randomization Following Acute Myocardial Infarction in Patients With Left Ventricular Systolic Dysfunction and Heart Failure
- Eplerenone in Patients With Systolic Heart Failure and Mild Symptoms
- Eplerenone and Atrial Fibrillation in Mild Systolic Heart Failure
- Extracellular Cardiac Matrix Biomarkers in Patients With Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction and Heart Failure
- Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy
- Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function
- Rationale and Design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF)
- Doxazosin, an alpha 1‐adrenoceptor antagonist: pharmacokinetics and concentration‐effect relationships in man.
- Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: The Randomized Double-Blind Reminder Study
- CP-346086
- Results of Bococizumab, A Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, from a Randomized, Placebo-Controlled, Dose-Ranging Study in Statin-Treated Subjects With Hypercholesterolemia
- The pharmacokinetics, antihistamine and concentration‐effect relationship of ebastine in healthy subjects.
- Pharmacokinetic and pharmacodynamic studies with two α‐adrenoceptor antagonists, doxazosin and prazosin in the rabbit
- The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial
- Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin
- Ebastine: the effect of a new antihistamine on psychomotor performance and autonomic responses in healthy subjects.
- Timing of Eplerenone Initiation and Outcomes in Patients with Heart Failure After Acute Myocardial Infarction Complicated by Left Ventricular Systolic Dysfunction: Insights from the EPHESUS Trial
- Oral bioavailability of trovafloxacin with and without food in healthy volunteers
- Clinical pharmacological studies with doxazosin.